Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1980-1986

  Salewski, Holger ^a   Bayer, Thomas A ^b,c   Eidhoff, Ulf ^a   Preuss, Ute ^a   Weggen, Sascha ^b   Scheidtmann, Karl Heinz ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS T ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CARCINOGENICITY; GENE MUTATION; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, VIRAL, TUMOR; BRAIN NEOPLASMS; CARCINOGENICITY TESTS; CELL LINE; CELL TRANSFORMATION, VIRAL; MUTATION; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; RATS; REPRODUCIBILITY OF RESULTS; RETROVIRIDAE; SIMIAN VIRUS 40; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; VIRUS INTEGRATION;

EID: 0033561744     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Evans, D. G., Farndon, P. A., Burnell, L. D., Gattamaneni, H. R., and Birch, J. M. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br. J. Cancer, 64: 959-961, 1991.
2. Itoh, H., Hirata, K., and Ohsato, K. Turcot's syndrome and familial adenomatous polyposis associated with brain tumors. Review of related literature. Int. J. Colorectal Dis., 8: 87-94, 1993.
3. Unden, A. B., Holmberg, E., Lundh-Rozell, B., Stahle-Backdahl, M., Zaphiropoulos, P. G., Toftgard, R., and Vorechovsky, I. Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in vivo mechanisms of PTCH inactivation. Cancer Res., 56: 4562-4565, 1996.
4. Mori, T., Nagase, H., Horii, A., Miyoshi, Y., Shimano, T., Nakatsuni, S., Aoki, T., Arakawa, H., Yanagisawa, A., Ushio, Y., Takano, S., Ogawa, M., Nakamura, M., Shihuya, M., Nishikawa, R., Matsutani, M., Hayashi, Y., Takahashi, H., Ikuta, F., Nishihira, S., and Nakamura, Y. Germ line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors. Genes Chromosomes Cancer, 9: 168-172, 1994.
5. Zurawel, R. H., Chiappa, S. A., Allen, C., and Raffel, C. Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res., 58: 896-899, 1998.
6. Gailani, M. R., Stähle-Bäckdahl, M., Leffell, D. J., Glynn, M., Zaphiropoulos, P. G., Pressman, C., Unden, A. B., Dean, M., Brash, D. E., Bale, A. E., and Toftgard, R. The role of the human homologue of Drosophila patched in sporadic basal cell carcinoma. Nat. Genet., 14: 78-81, 1996.
7. Pietsch, T., Waha, A., Koch, A., Kraus, J., Albrecht, S., Tonn, J., Sörensen, N., Berthold, F., Henk, B., Schmandt, N., Wolf, H. K., von Deimling, A., Wainwright, B., Chenevix-Trench, G., Wiestler, O. D., and Wicking, C. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res., 57: 2085-2088, 1997.
8. Reardon, D. A., Michalkiewicz, E., Boyett, J. M., Sublett, J. E., Entrekin, R. E., Ragsdale, S. T., Valentine, M. B., Behm, F. G., Li, H., Heideman, R. L., Kun, L. E., Shapiro, D. N., and Look, A. T. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res., 57: 4042-4047, 1997.
9. Bigner, S. H., and Vogelstein, B. Cytogenetics and molecular genetics of malignant gliomas and medulloblastomas. Brain Pathol., 1: 12-18, 1990.
10. Reiner, O., Carrozzo, R., Shen, Y., Wehnert, M., Faustinella, F., Dobyns, W. B., Caskey, C. D., and Ledbetter, D. H. Isolation of a Miller-Dieker lissencephaly gene containing G protein β subunit like repeats. Nature (Lond.), 364: 717-721, 1993.
11. Meroni, G., Reymond, A., Alcaly, M., Borsani, G., Tanigami, A., Tonlorenzi, R., Nigro, C. L., Messali, S., Zollo, M., Ledbetter, D. H., Brent, R., Ballabio, A., and Carrozzo, R. Rox, a novel bHLHZip protein expressed in quiescent cells, that heterodimerizes with max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J., 16: 2892-2906, 1997.
12. Makos, M., Nelkin, B. D., Chazin, V. R., Cavanee, W. K., Brodeur, G. M., and Baylin, S. B. DNA hypermethylation is associated with 17p allelic loss in neuronal tumors. Cancer Res., 53: 2715-2718, 1993.
13. Benchimol, S., Lamb, P., Crawford, L. V., Sheer, D., Shours, T. B., Bruns, G. A. P., and Peacock, J. Transformation associated p53 protein is encoded by a gene on human chromosome 17. Somat. Cell. Mol. Genet., 11: 505-509, 1985.
14. Koch, A., Tonn, J., Waha, A., Sörensen, N., Wiestler, O. D., and Pietsch, T. Inactivation of the HIC-1 tumor suppressor gene in medulloblastomas. Proc. Am. Assoc. Cancer Res., 38: 3814A, 1997.
15. Phelan, C. M., Liu, L., Ruttledge, M. H., Muntzning, K., Ridderheim, P. A., and Collins, V. P. Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours. Hum. Genet., 96: 684-690, 1995.
16. Ohgaki, H., Eibl, R. H., Wiestler, O. D., Yasargil, M. G., Newcomb, E. W., and Kleihues, P. p53 mutations in nonastrocytic human brain tumors. Cancer Res., 51: 6202-6205, 1991.
17. Conzen, S. D., and Cole, C. N. The transforming proteins of simian virus 40. Semin. Virol., 5: 349-356, 1994.
18. Kao, C., Huang, J., Wu, S. Q., Hauser, P., and Reznikoff, C. A. Role of SV40 T antigen binding to pRB and p53 in multistep transformation in vitro of human uroepithelial cells. Carcinogenesis (Lond.), 14: 2297-2302, 1993.
19. Ludlow, J. W., and Skuse, G. R. Viral oncoproteins binding to pRb, p107, p130, and p300. Virus Res., 35: 113-121, 1995.
20. Eckner, R., Ludlow, J. W., Lill, N. L., Oldread, E., Arany, Z., Modjtahedi, N., DeCaprio, J. A., Livingston, D. M., and Morgan, J. A. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol., 16: 3454-3464, 1996.
21. Müller, E., and Scheidtmann, K. H. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates tumor suppressor protein p53. Oncogene, 10: 1175-1185, 1995.
22. Chang, T. H., and Schlegel, R. SV40 T antigen increases the expression and activities of p34cdc2, cyclin A, and cyclin B prior to immortalization of human diploid fibroblasts. J. Cell. Biochem., 60: 161-172, 1996.
23. Valentinis, B., Porcu, P. L., Quinn, K., and Baserga, R. The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen. Oncogene, 9: 825-831, 1994.
24. Zhu, J, Rice, P. W., Gorsch, L., Abate, M., and Cole, C. N. Transformation of a continues rat embryo fibioblast cell line requires three separate domains of SV40 large T antigen. J. Virol., 66: 2780-2791, 1992.
25. Dobbelstein, M., Arthur, A. K., Dehde, S., van Zee, K, Dickmanns, A., and Fanning, E. Intracistronic complementation reveals a new function of SV40 T antigen that co-operates with Rb and p53 binding to stimulate DNA synthesis in quiescent cells. Oncogene, 7: 837-847, 1992.
26. Carbone, M., Rizzo, P., and Pass, H. I. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene, 15: 1877-1888, 1997.
27. Wiestler, O. D., Brüstle, O., Eibl, R. H., Radner, H., von Deimling, A., Plate, K., Aguzzi, A., and Kleihues, P. A new approach to the molecular basis of neoplastic transformation in the brain. Neuropathol. Appl. Neurobiol., 18: 443-453, 1992.
28. Wiestler, O. D., Brüstle, O., Eibl, R. H., Radner, H., Aguzzi, A., and Kleihues, P. Retrovirus-mediated oncogene transfer into neural transplants. Brain Pathol., 2: 47-59, 1992.
29. Van Dyke, T. A., Finlay, C., Miller, D., Lozano, G., and Levine, A. J. Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice. J. Virol., 61: 2029-2032, 1987.
30. Chen, J., Tobin, G. J., Pipas, J. M., and van Dyke, T. T-antigen mutant activities in vivo: roles of p53 and pRb binding in tumorigenesis of the choroid plexus. Oncogene, 7: 1167-1175, 1992.
31. Held, W. A., Pazik, J., O'Brien, J. G., Kerns, K., Gobey, M., Meis, R., Kenny, L., and Rustum, Y. Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res., 54: 6489-6495, 1994.
32. Weggen, S., Bayer, T., Scheidtmann, K., Pietsch, T., and Wiestler, O. D. Characterization of neural cell lines derived from SV40 large T antigen induced primitive neuroectodermal tumors. Brain Pathol., 7: 731-739, 1997.
33. McCarthy, S. A., Symonds, H. S., and Van Dyke, T. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. Proc. Natl. Acad. Sci. USA, 91: 3979-3983, 1994.
34. Zheng, D. Q., Vayssiere, J. L., Petit, P. X., Lecoeur, H., Spatz, A., Mignotte, B., and Feunteun, J. Apoptosis is antagonized by large T antigens in the pathway to immortalization by polyomaviruses. Oncogene, 9: 3345-3351, 1994.
35. Jat, P. S., Cepko, C. L., Mulligan, R. C., and Sharp, P. A. Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens. Mol. Cell. Biol., 6: 1204-1217, 1986.
36. Wulf, E., Deboben, A., Bautz, F. A., Faulstich, H., and Wieland, T. Fluorescent phallotoxin, a tool for the visualization of cellular actin. Proc. Natl. Acad. Sci. USA, 76: 4498-4502, 1979.
37. Harlow, E., Crawford, L. V., Pirn, D. C., and Williamson, N. M. Monoclonal antibodies specific for the SV40 tumor antigens. J. Virol. 39: 861-869, 1981.
38. Gumey, E. G., Harrison, R. O., and Fenno, J. Monoclonal antibodies against simian virus 40 antigens: evidence for distinct subclasses of large T antigen and for similarities among nonviral T antigens. J. Virol., 34: 752-763, 1980.
39. Scheidtmann, K. H., Landsberg, G., and Grässmann, A. Enhanced kinase activity in SV40-transformed cells may be compensated by enhanced phosphatase activity in revertants as reflected by phosphorylation of p53. Int. J. Oncol., 5: 1353-1362, 1994.
40. Scheidtmann, K. H., and Landsberg, G. UV irradiation leads to transient increase in stability and phosphorylation of tumor suppressor protein p53. Int. J. Oncol., 9: 1277-1285, 1996.
41. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 86: 5547-5551, 1989.
42. Chen, C., and Okayama, H. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7: 2745-2751, 1987.
43. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
44. O'Neill, F., Cohen, S., and Renzetti, L. Temperature dependency for maintenance of transformation in mouse cells transformed by simian virus 40 tsA mutants. J. Virol., 35: 233-245, 1980.
45. Pollack, R., Osborn, M., and Weber, K. Patterns of organization of actin and myosin in normal and transformed cultured cells. Proc. Natl. Acad. Sci. USA, 72: 994-998, 1975.
46. Rassoulzadegan, M., Perbal, B., and Cuzin, F. Growth control in simian virus 40 transformed rat cells: temperature-independent expression of the transformed phenotype in tsA transformants derived by agar selection. J. Virol., 28: 1-5, 1978.
47. Ewald, D., Li, M., Efrat, S., Auer, G., Wall, R. J., Furth, P. A., and Hennighausen, L. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (Washington DC), 273: 1384-1386, 1996.
48. Ruppert, J. M., and Stillman, B. Analysis of a protein-binding domain of p53. Mol. Cell. Biol., 13: 3811-3820, 1993.
49. Geissler, E., and Theile, M. Virus-induced gene mutations of eukaryotic cells. Hum. Genet. 63: 1-12, 1983.
50. Ray, F. A. Simian virus 40 large T antigen induces chromosome damage that precedes and coincides with complete neoplastic transformation. In: G. Brabanti-Brodano, M. Bendinelli, and H. Friedman (eds.), DNA Tumor Viruses: Oncogenic Mechanisms, pp. 15-26. New York, Plenum Press, 1995.
51. Chang, T. H.-T., Ray, F. A., Thompson, D. A., and Schlegel, R. Disregulation of mitotic checkpoints and regulatory proteins following acute expression of SV40 large T antigen in diploid human cells. Oncogene, 14: 2383-2393, 1997.
52. Moorwood, K., Price, T. N. C., and Mayne, L. V. Mutation of p53 is not a prerequisite for immortalization of human fibroblasts by SV40 T antigen. Exp. Cell Res., 223: 308-313, 1996.
53. Moore, M., Teresky, A. K., Levine, A. J., and Seiberg, M. p53 mutations are not selected for in simian virus 40 T-antigen-induced tumors from transgenic mice. J. Virol., 66: 641-649, 1992.
54. Hollstein, M., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sorli, T., Hovig, E., Smith-Sorensen, B., Montesano, R., and Harris, C. C. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 22: 3551-3555, 1994.
55. Rainwater, R., Parks, D., Anderson, M. E., Tegtmeyer, P., and Mann, K. Role of cysteine residues in regulation of p53 function. Mol. Cell. Biol., 15: 3892-3902, 1995.
56. Gualberto, A., Aldapa, K., Kozakiewicz, K., and Tlsty, T. D. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl. Acad. Sci. USA, 95: 5166-5171, 1998.
57. Hartwell, L. Defects in a cell cycle check point may be responsible for the genetic instability of cancer cells. Cell, 71: 543-546, 1992.
58. Geissler, E. SV40 and human brain tumors. Prog. Med. Virol., 37: 211-222, 1990.